SCIENTIFIC BACKGROUND

EPCAM, MLH1, MSH2, MSH6, PMS2

Category:

Scientific Background

Hereditary non-polyposis colorectal cancer (HNPCC), is an autosomal dominant disorder which can run in families and accounts for about 1-4% of colorectal cancer cases. Patients with HNPCC usually do not show any polyps or if they show, they will be in small numbers. HNPCC was found to be associated with germline mutations in the DNA mismatch repair (MMR*) genes which can cause mistakes in the repair of the DNA during replication, leading to uncontrolled growth. Another gene that was found to cause HNPCC is EPCAM. Large deletions in this gene can lead to reduction in MSH2 expression resulting in the incorrect repair of the DNA and development of HNPCC.

 

PreSENTIA hereditary Colorectal Non-Polyposis cancer panel tests for numerous germline mutations that could cause colorectal cancers in the future. Identifying germline mutations associated with cancer susceptibility empowers healthcare providers and patients, as it allows them to take better and more informed decisions.

 

*MMR genes: MLH1, MSH2, MSH6 and PMS2

 

Who is this test for?

You should get tested if you meet at least one of the criteria below:

You have been diagnosed with colorectal cancer at a young age (<50)

You have been diagnosed with Lynch syndrome

You have been diagnosed with Lynch syndrome-related cancers†, regardless of age

You have relatives with any Lynch-associated cancers†

You have one or more family members who had cancer before age 50.

 

How many genes are tested in this panel?

5 genes

 

How many hereditary cancer syndromes are associated with this panel?

2 Hereditary cancer syndromes are associated with this panel. These are:

• Constitutional mismatch repair syndrome (EPCAM, MSH2, MSH6, MLH1, PMS2)

• Lynch syndrome (EPCAM, MLH1, MSH2, MSH6, PMS2)

 

References and more information: 

American cancer society

Duraturo F, Liccardo R, De Rosa M, Izzo P. Genetics, diagnosis and treatment of Lynch syndrome: Old lessons and current challenges. Oncol Lett. 2019 Mar;17(3):3048-3054. doi: 10.3892/ol.2019.9945. Epub 2019 Jan 18. PMID: 30867733; PMCID: PMC6396136.

Edwards, P. and Monahan, K.J., 2022. Diagnosis and management of Lynch syndrome. Frontline Gastroenterology, 13(e1), pp.e80-e87.

Moller P, Seppala TT, Bernstein I, et al. Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the prospective Lynch syndrome database. Gut 2018; 67: 1306– 1316.

Kanth P, Grimmett J, Champine M, Burt R, Samadder NJ. Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management. Am J Gastroenterol. 2017 Oct;112(10):1509-1525. doi: 10.1038/ajg.2017.212. Epub 2017 Aug 8. PMID: 28786406.

GENES

EPCAM, MLH1, MSH2, MSH6, PMS2
How to order

LATEST ARTICLES

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact ...

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc...

Read more

Reproductive health is a fundamental aspect of human well-being, affecting individuals and communities worldwide [1]. It encompasses a wide range of ...

Read more

It seems as though everyone is talking about artificial intelligence, usually referred to as AI, these days! Indeed, not only are AI tools now access...

Read more

Orphan drugs are those developed specifically for the treatment of rare diseases. Within the pharmaceutical industry, the drug development process is...

Read more

A study of 629 pregnancies with ultrasound-detected anomalies found that exome sequencing identified pathogenic variants in 14% of cases. The detecti...

Read more

Breast cancer is a type of cancer that originates in the breast cells. Genetic changes in the DNA of the healthy breast cells can lead to the formati...

Read more